JPS56152415A - Pharmaceutical blend - Google Patents

Pharmaceutical blend

Info

Publication number
JPS56152415A
JPS56152415A JP4569081A JP4569081A JPS56152415A JP S56152415 A JPS56152415 A JP S56152415A JP 4569081 A JP4569081 A JP 4569081A JP 4569081 A JP4569081 A JP 4569081A JP S56152415 A JPS56152415 A JP S56152415A
Authority
JP
Japan
Prior art keywords
pharmaceutical blend
blend
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4569081A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6360008B2 (ru
Inventor
Aasaa Kapuran Maarei
Piitaa Guranatetsuku Aruhonsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS56152415A publication Critical patent/JPS56152415A/ja
Publication of JPS6360008B2 publication Critical patent/JPS6360008B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP4569081A 1980-03-31 1981-03-30 Pharmaceutical blend Granted JPS56152415A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
JPS56152415A true JPS56152415A (en) 1981-11-26
JPS6360008B2 JPS6360008B2 (ru) 1988-11-22

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4569081A Granted JPS56152415A (en) 1980-03-31 1981-03-30 Pharmaceutical blend

Country Status (30)

Country Link
JP (1) JPS56152415A (ru)
KR (1) KR860000841B1 (ru)
AR (1) AR225500A1 (ru)
AT (1) AT370996B (ru)
AU (1) AU541056B2 (ru)
BE (1) BE888209A (ru)
CA (1) CA1162479A (ru)
CH (1) CH647481A5 (ru)
CS (1) CS246051B2 (ru)
DD (1) DD157762A5 (ru)
DE (1) DE3112272A1 (ru)
DK (1) DK158564C (ru)
ES (1) ES500869A0 (ru)
FI (1) FI70670C (ru)
FR (1) FR2480605A1 (ru)
GB (1) GB2074028B (ru)
GR (1) GR72769B (ru)
HU (1) HU183379B (ru)
IE (1) IE51070B1 (ru)
IL (1) IL62517A (ru)
IT (1) IT1170838B (ru)
LU (1) LU83270A1 (ru)
NL (1) NL8101531A (ru)
NO (1) NO156675C (ru)
NZ (1) NZ196519A (ru)
PH (1) PH17152A (ru)
PT (1) PT72774B (ru)
SE (1) SE455045B (ru)
SU (1) SU1056893A3 (ru)
ZA (1) ZA812084B (ru)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0321252A (ja) * 1988-11-14 1991-01-30 Bristol Myers Squibb Co シスプラチン高張液
JP2001501173A (ja) * 1996-08-23 2001-01-30 アルザ コーポレイション シスプラチン化合物を含有するリポソーム
US7224217B2 (en) 2004-03-26 2007-05-29 Onkyo Corporation Switching amplifier
JP2012521440A (ja) * 2009-03-26 2012-09-13 ウォーソー・オーソペディック・インコーポレーテッド 損傷部位への活性剤の優先的分配のための組成物および方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0321252A (ja) * 1988-11-14 1991-01-30 Bristol Myers Squibb Co シスプラチン高張液
JP2001501173A (ja) * 1996-08-23 2001-01-30 アルザ コーポレイション シスプラチン化合物を含有するリポソーム
US7224217B2 (en) 2004-03-26 2007-05-29 Onkyo Corporation Switching amplifier
JP2012521440A (ja) * 2009-03-26 2012-09-13 ウォーソー・オーソペディック・インコーポレーテッド 損傷部位への活性剤の優先的分配のための組成物および方法

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (ru) 1984-05-11
DE3112272C2 (ru) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (ru) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (ru) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
ZA813465B (en) Pharmaceutical composition
PH25637A (en) Dipyridamole-containing pharmaceutical form
DE3172028D1 (en) Pharmaceutical formulation
ZA817187B (en) Medicament based on 2-amino-6-trifluoromethoxy-benzothiazole
PH16539A (en) Pharmaceutical preparation having improved properties
PH19245A (en) Pharmaceutical preparations
PH17562A (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
JPS56139420A (en) Drug
GB2072504B (en) Pharmaceutical compositions
JPS56152415A (en) Pharmaceutical blend
ZA815700B (en) Pharmaceutical compositions
JPS56150088A (en) Pyrimidyl-quinazoline,its manufacture and pharmaceutical blend containing it
ZA818221B (en) Pharmaceutical compounds
JPS56145224A (en) Pharmaceutical blend
JPS56125316A (en) Pharmaceutic blend
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
ZA817684B (en) Pharmaceutical compositions
HK90087A (en) Pharmaceutical formulation
ZA815175B (en) Pharmaceutical composition
PH18681A (en) Methoxsalem dosage forms
JPS57154128A (en) Medicinal composition
PT73810B (en) Pharmaceutical compositions
ZA812902B (en) Pharmaceutical compositions
KE3581A (en) Pharmaceutical formulation